Aquestive Therapeutics Inc (AQST)

Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	1.57% 13.21	13.00	13.24	11.13	10.68
Cost Of Revenue	2.48% 4.679	4.798	6.617	4.737	-
Gross Profit	3.94% 8.527	8.204	6.624	6.397	-
Operating Expenses	17.55% 12.44	10.58	10.83	11.00	35.48
Interest Income/Expense	80.97% 2.273	1.256	1.373	1.435	1.65
Benefits Costs and Expenses	39.79% 21.22	15.18	18.75	3.066	23.03
Costs And Expenses	11.30% 17.12	15.38	17.45	15.74	33.74
Depreciation and Amortization	76.89% 0.467	0.264	0.289	0.325	0.397
Operating Income/Loss	64.54% -3.911	-2.377	-4.209	-4.605	-10.71
Income/Loss From Continuing Operations Before Tax	268.28% -8.01	-2.175	-5.508	8.068	-12.35
Income Tax Expense/Benefit	172.14% 0.101	-0.14	0.284	-	-
Income/Loss From Continuing Operations After Tax	298.57% -8.111	-2.035	-5.792	8.068	-12.35
Net Income/Loss	298.57% -8.111	-2.035	-5.792	8.068	-12.35
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	96.90% 2.0031	64.68	57.35	55.63	1.9062
Diluted Average Shares	100.40% -0.2579	64.68	57.35	73.79	1.9062
Basic Earnings Per Share	333.33% -0.13	-0.03	-0.10	0.15	-0.22
Diluted Earnings Per Share	333.33% -0.13	-0.03	-0.10	0.11	-0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-